JACOBS LEVY EQUITY MANAGEMENT, INC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 94 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$511,000
-65.4%
60,008
-64.0%
0.00%
-72.7%
Q1 2021$1,476,000
-41.0%
166,726
-18.1%
0.01%
-50.0%
Q4 2020$2,503,000
+5.8%
203,644
-29.9%
0.02%
-12.0%
Q3 2020$2,366,000
+34.6%
290,698
+58.7%
0.02%
+31.6%
Q2 2020$1,758,000
+207.9%
183,120
+118.1%
0.02%
+171.4%
Q1 2020$571,000
+79.6%
83,979
+293.2%
0.01%
+133.3%
Q4 2019$318,000
+43.2%
21,360
-1.4%
0.00%0.0%
Q3 2019$222,000
-11.6%
21,660
+45.0%
0.00%
-40.0%
Q1 2016$251,00014,9380.01%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Vivo Capital, LLC 1,787,091$20,462,0006.02%
INTERWEST VENTURE MANAGEMENT CO 1,599,592$18,315,0003.89%
NEXTHERA CAPITAL LP 263,600$3,018,0001.54%
SPHERA FUNDS MANAGEMENT LTD. 385,301$4,412,0000.86%
RA Capital Management 354,200$4,056,0000.50%
DAFNA Capital Management LLC 35,977$412,0000.35%
Boxer Capital, LLC 138,331$1,584,0000.35%
SABBY MANAGEMENT, LLC 238,907$2,735,0000.15%
Monashee Investment Management LLC 31,500$361,0000.14%
Lombard Odier Asset Management (USA) Corp 100,000$1,145,0000.11%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders